Cowen launched coverage of Apollo Endosurgery (NASDAQ:APEN) with an “outperform” rating and $13 price target. The stock closed at $7.64 on Dec. 14. APEN is focused on design, development and commercialization of novel...
Stifel launched coverage of Apollo Endosurgery (NASDAQ:APEN) with a “buy” rating and $12 price target. The stock closed at $8.59 on Dec. 8. Apollo Endosurgery is a medical technology company focused on design...